Lillian Vickery

Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: Confirmation by multivariate analysis that modulation of type ii collagen and aggrecan degradation peptides parallels pathologic changes

Steven L. Settle, Lillian Vickery, Olga V. Nemirovskiy et al. · Arthritis & Rheumatism · 2010 · 69 citations

Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

Mark E. Schnute, Patrick O’Brien, Joe Nahra et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 48 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +8

Chapter 17 Regulation by nicotine of midbrain dopamine neurons

Thomas C. Westfall, Giampaolo Mereu, Lillian Vickery et al. · Progress in brain research · 1989 · 35 citations

Nicotine, Physiology, Midbrain Dopamine Neurons +6

Progenipoietins

Philip R. Streeter, Nancy I Minster, Larry E. Kahn et al. · Experimental Hematology · 2001 · 32 citations · Full text

Protein geranylgeranylation controls collagenase expression in osteoarthritic cartilage

Francis M. Sverdrup, Matthew Yates, Lillian Vickery et al. · Osteoarthritis and Cartilage · 2010 · 25 citations

Rheumatology, Cartilage Degeneration, Molecular Biology +8